FSMAX | MMELX | FSMAX / MMELX | |
Total Expense Ratio | 0.04 | 0.96 | 4% |
Annual Report Gross Expense Ratio | 0.04 | 0.97 | 4% |
Fund Existence | 14 years | 25 years | - |
Gain YTD | -15.097 | -12.853 | 117% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 36.5B | 3.81B | 957% |
Annual Yield % from dividends | 0.53 | 0.49 | 109% |
Returns for 1 year | 0.35 | -18.98 | -2% |
Returns for 3 years | 5.53 | -29.49 | -19% |
Returns for 5 years | 60.85 | -25.23 | -241% |
Returns for 10 years | 44.71 | -26.37 | -170% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FAVCX | 22.02 | N/A | N/A |
Fidelity Advisor Equity Value C | |||
FRBRX | 116.27 | N/A | N/A |
Franklin Biotechnology Discovery R6 | |||
PRMTX | 146.31 | N/A | N/A |
T. Rowe Price Comm & Tech Investor | |||
JIJIX | 12.94 | N/A | N/A |
JHancock International Dynamic Gr I | |||
WAFMX | 3.43 | -0.04 | -1.15% |
Wasatch Frontier Emerg Sm Countrs Inv |